Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD
Dr. Shuvro Roy and Dr. Michael Levy discuss satralizumab for treating relapsing MOGAD, current management challenges, and the encouraging results of this new therapy. Read more about this abstract.
25 Kesä 1min
Safety and Efficacy of Adjunct Dexamethasone in Adults with Herpes Simplex Virus Encephalitis in The UK - Part 3
In part three of this series, Dr. Aaron Zelikovich discusses the clinical outcomes seen during and after the acute infection and how these findings can guide physicians in counseling their patients. ...
24 Kesä 2min
The Role of Social Media in Neurology Trainees' Professional Identity Formation - Part 2
In part two of this series, Dr. Jeff Ratliff and Dr. Gabriela Figueiredo Pucci discuss the lessons and experiences that happen in neurology-related social media interaction. Show citation: Pucci GF,...
23 Kesä 1min
Neurology Wait Times After Primary Care or Emergency Department Visits - Part 2
In part two of this series, Dr. Stacey Clardy and Dr. John Ney discuss the primary limitation of using claims data to estimate wait times for neurology services, particularly in rural areas or for sub...
22 Kesä 3min
Neurology Wait Times After Primary Care or Emergency Department Visits - Part 2
In part two of this series, Dr. Stacey Clardy and Dr. John Ney discuss the primary limitation of using claims data to estimate wait times for neurology services, particularly in rural areas or for sub...
22 Kesä 3min
The Role of Social Media in Neurology Trainees' Professional Identity Formation -Part 1
In part one of this two-part series, Dr. Jeff Ratliff and Dr. Gabriela Figueiredo Pucci shares the most important takeaway about professional identity formation among those actively engaged in neurolo...
19 Kesä 1min
Neurology Wait Times After Primary Care or Emergency Department Visits - Part 1
In part one of this series, Dr. Stacey Clardy and Dr. John Ney break down the difference between mean and median wait times for new neurology appointments. Show citation: Laffargue EK, Van Der Goes D...
18 Kesä 2min
